Listed

Acrivon Therapeutics, Inc.

ACRVNasdaqCIK 1781174HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$18.7m, Q2 FY2026
Net income−$18.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m10.3Research and development, Q3 FY2023, three months to 2023-09-30$10.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0000950170-24-125929.Report this figure15.5Research and development, Q4 FY2023, three months to 2023-12-31$15.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-27, accession 0000950170-25-046056. Derived: 12-month figure less the 9-month figure.Report this figure11.5Research and development, Q1 FY2024, three months to 2024-03-31$11.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0000950170-25-071427.Report this figure15.0Research and development, Q2 FY2024, three months to 2024-06-30$15.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0000950170-25-108054.Report this figure18.9Research and development, Q3 FY2024, three months to 2024-09-30$18.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure18.6Research and development, Q4 FY2024, three months to 2024-12-31$18.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-115123. Derived: 12-month figure less the 9-month figure.Report this figure15.4Research and development, Q1 FY2025, three months to 2025-03-31$15.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure16.2Research and development, Q2 FY2025, three months to 2025-06-30$16.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure13.6Research and development, Q3 FY2025, three months to 2025-09-30$13.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure14.7Research and development, Q4 FY2025, three months to 2025-12-31$14.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001193125-26-115123. Derived: 12-month figure less the 9-month figure.Report this figure15.2Research and development, Q1 FY2026, three months to 2026-03-31$15.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure13.8Research and development, Q2 FY2026, three months to 2026-06-30$13.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure
Operating income$m(16.1)Operating income, Q3 FY2023, three months to 2023-09-30−$16.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-125929.Report this figure(21.1)Operating income, Q4 FY2023, three months to 2023-12-31−$21.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0000950170-25-046056. Derived: 12-month figure less the 9-month figure.Report this figure(17.7)Operating income, Q1 FY2024, three months to 2024-03-31−$17.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0000950170-25-071427.Report this figure(21.4)Operating income, Q2 FY2024, three months to 2024-06-30−$21.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0000950170-25-108054.Report this figure(25.1)Operating income, Q3 FY2024, three months to 2024-09-30−$25.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure(25.0)Operating income, Q4 FY2024, three months to 2024-12-31−$25.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115123. Derived: 12-month figure less the 9-month figure.Report this figure(21.7)Operating income, Q1 FY2025, three months to 2025-03-31−$21.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure(22.6)Operating income, Q2 FY2025, three months to 2025-06-30−$22.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure(19.7)Operating income, Q3 FY2025, three months to 2025-09-30−$19.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure(20.1)Operating income, Q4 FY2025, three months to 2025-12-31−$20.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115123. Derived: 12-month figure less the 9-month figure.Report this figure(19.9)Operating income, Q1 FY2026, three months to 2026-03-31−$19.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure(18.7)Operating income, Q2 FY2026, three months to 2026-06-30−$18.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure
Net income$m(14.5)Net income, Q3 FY2023, three months to 2023-09-30−$14.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-125929.Report this figure(19.3)Net income, Q4 FY2023, three months to 2023-12-31−$19.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0000950170-25-046056. Derived: 12-month figure less the 9-month figure.Report this figure(16.5)Net income, Q1 FY2024, three months to 2024-03-31−$16.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure(18.8)Net income, Q2 FY2024, three months to 2024-06-30−$18.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure(22.4)Net income, Q3 FY2024, three months to 2024-09-30−$22.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure(22.8)Net income, Q4 FY2024, three months to 2024-12-31−$22.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115123. Derived: 12-month figure less the 9-month figure.Report this figure(19.7)Net income, Q1 FY2025, three months to 2025-03-31−$19.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure(21.0)Net income, Q2 FY2025, three months to 2025-06-30−$21.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure(18.2)Net income, Q3 FY2025, three months to 2025-09-30−$18.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure(19.0)Net income, Q4 FY2025, three months to 2025-12-31−$19.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001193125-26-115123. Derived: 12-month figure less the 9-month figure.Report this figure(19.0)Net income, Q1 FY2026, three months to 2026-03-31−$19.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure(18.0)Net income, Q2 FY2026, three months to 2026-06-30−$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure
Diluted EPS$ per share(0.66)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0000950170-24-125929.Report this figurenot reported(0.73)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0000950170-25-071427.Report this figure(0.52)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0000950170-25-108054.Report this figure(0.59)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figurenot reported(0.51)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure(0.55)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure(0.47)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figurenot reported(0.49)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure(0.43)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure
Basic EPS$ per share(0.66)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0000950170-24-125929.Report this figurenot reported(0.73)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0000950170-25-071427.Report this figure(0.52)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0000950170-25-108054.Report this figure(0.59)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figurenot reported(0.51)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure(0.55)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure(0.47)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figurenot reported(0.49)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure(0.43)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure

Balance sheet

Cash and equivalents$41.4m, Q2 FY2026
Shareholders' equity$86.7m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m29.9Cash and equivalents, Q3 FY2023, at 2023-09-30$29.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0000950170-24-125929.Report this figure36.0Cash and equivalents, FY2023, at 2023-12-31$36.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-27, accession 0000950170-25-046056.Report this figure24.6Cash and equivalents, Q1 FY2024, at 2024-03-31$24.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0000950170-25-071427.Report this figure46.0Cash and equivalents, Q2 FY2024, at 2024-06-30$46.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0000950170-25-108054.Report this figure43.4Cash and equivalents, Q3 FY2024, at 2024-09-30$43.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure39.8Cash and equivalents, FY2024, at 2024-12-31$39.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0001193125-26-115123.Report this figure39.2Cash and equivalents, Q1 FY2025, at 2025-03-31$39.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure41.9Cash and equivalents, Q2 FY2025, at 2025-06-30$41.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure35.4Cash and equivalents, Q3 FY2025, at 2025-09-30$35.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure41.5Cash and equivalents, FY2025, at 2025-12-31$41.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure34.1Cash and equivalents, Q1 FY2026, at 2026-03-31$34.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure41.4Cash and equivalents, Q2 FY2026, at 2026-06-30$41.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure
Current assets$m144Current assets, Q3 FY2023, at 2023-09-30$144.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061553.Report this figure130Current assets, FY2023, at 2023-12-31$129.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-27, accession 0000950170-25-046056.Report this figure112Current assets, Q1 FY2024, at 2024-03-31$112.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059084.Report this figure182Current assets, Q2 FY2024, at 2024-06-30$182.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-095760.Report this figure189Current assets, Q3 FY2024, at 2024-09-30$189.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-125929.Report this figure182Current assets, FY2024, at 2024-12-31$181.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001193125-26-115123.Report this figure151Current assets, Q1 FY2025, at 2025-03-31$151.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071427.Report this figure138Current assets, Q2 FY2025, at 2025-06-30$138.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0000950170-25-108054.Report this figure130Current assets, Q3 FY2025, at 2025-09-30$130.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure120Current assets, FY2025, at 2025-12-31$120.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure99.2Current assets, Q1 FY2026, at 2026-03-31$99.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure91.5Current assets, Q2 FY2026, at 2026-06-30$91.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure
Total assets$m151Total assets, Q3 FY2023, at 2023-09-30$151.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-061553.Report this figure138Total assets, FY2023, at 2023-12-31$138.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-27, accession 0000950170-25-046056.Report this figure121Total assets, Q1 FY2024, at 2024-03-31$120.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059084.Report this figure231Total assets, Q2 FY2024, at 2024-06-30$230.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-095760.Report this figure215Total assets, Q3 FY2024, at 2024-09-30$214.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0000950170-24-125929.Report this figure197Total assets, FY2024, at 2024-12-31$196.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0001193125-26-115123.Report this figure176Total assets, Q1 FY2025, at 2025-03-31$176.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0000950170-25-071427.Report this figure159Total assets, Q2 FY2025, at 2025-06-30$158.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0000950170-25-108054.Report this figure145Total assets, Q3 FY2025, at 2025-09-30$145.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure130Total assets, FY2025, at 2025-12-31$129.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure108Total assets, Q1 FY2026, at 2026-03-31$107.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure99.1Total assets, Q2 FY2026, at 2026-06-30$99.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure
Current liabilities$m9.3Current liabilities, Q3 FY2023, at 2023-09-30$9.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-061553.Report this figure13.3Current liabilities, FY2023, at 2023-12-31$13.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-27, accession 0000950170-25-046056.Report this figure9.0Current liabilities, Q1 FY2024, at 2024-03-31$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059084.Report this figure11.3Current liabilities, Q2 FY2024, at 2024-06-30$11.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-095760.Report this figure14.8Current liabilities, Q3 FY2024, at 2024-09-30$14.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-125929.Report this figure17.2Current liabilities, FY2024, at 2024-12-31$17.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0001193125-26-115123.Report this figure13.6Current liabilities, Q1 FY2025, at 2025-03-31$13.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071427.Report this figure13.4Current liabilities, Q2 FY2025, at 2025-06-30$13.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0000950170-25-108054.Report this figure14.9Current liabilities, Q3 FY2025, at 2025-09-30$14.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure15.7Current liabilities, FY2025, at 2025-12-31$15.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure11.1Current liabilities, Q1 FY2026, at 2026-03-31$11.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure11.4Current liabilities, Q2 FY2026, at 2026-06-30$11.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure
Total liabilities$m12.9Total liabilities, Q3 FY2023, at 2023-09-30$12.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-061553.Report this figure17.1Total liabilities, FY2023, at 2023-12-31$17.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-27, accession 0000950170-25-046056.Report this figure12.5Total liabilities, Q1 FY2024, at 2024-03-31$12.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059084.Report this figure14.5Total liabilities, Q2 FY2024, at 2024-06-30$14.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0000950170-24-095760.Report this figure17.8Total liabilities, Q3 FY2024, at 2024-09-30$17.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0000950170-24-125929.Report this figure19.8Total liabilities, FY2024, at 2024-12-31$19.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0001193125-26-115123.Report this figure16.0Total liabilities, Q1 FY2025, at 2025-03-31$16.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0000950170-25-071427.Report this figure15.5Total liabilities, Q2 FY2025, at 2025-06-30$15.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0000950170-25-108054.Report this figure16.7Total liabilities, Q3 FY2025, at 2025-09-30$16.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure17.2Total liabilities, FY2025, at 2025-12-31$17.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure12.3Total liabilities, Q1 FY2026, at 2026-03-31$12.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure12.4Total liabilities, Q2 FY2026, at 2026-06-30$12.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure
Shareholders' equity$m138Shareholders' equity, Q3 FY2023, at 2023-09-30$138.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0000950170-24-125929.Report this figure121Shareholders' equity, FY2023, at 2023-12-31$121.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0001193125-26-115123.Report this figure108Shareholders' equity, Q1 FY2024, at 2024-03-31$108.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure216Shareholders' equity, Q2 FY2024, at 2024-06-30$216.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure197Shareholders' equity, Q3 FY2024, at 2024-09-30$196.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure177Shareholders' equity, FY2024, at 2024-12-31$176.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure160Shareholders' equity, Q1 FY2025, at 2025-03-31$160.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure143Shareholders' equity, Q2 FY2025, at 2025-06-30$143.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure129Shareholders' equity, Q3 FY2025, at 2025-09-30$128.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure113Shareholders' equity, FY2025, at 2025-12-31$112.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure95.5Shareholders' equity, Q1 FY2026, at 2026-03-31$95.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure86.7Shareholders' equity, Q2 FY2026, at 2026-06-30$86.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure

Cash flow

Operating cash flow−$14.9m, Q2 FY2026
Capital expenditure$87.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(9.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0000950170-24-125929. Derived: 9-month figure less the 6-month figure.Report this figure(12.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$12.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0000950170-25-046056. Derived: 12-month figure less the 9-month figure.Report this figure(17.1)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$17.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0000950170-25-071427.Report this figure(13.9)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$13.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0000950170-25-108054. Derived: 6-month figure less the 3-month figure.Report this figure(17.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$17.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-280215. Derived: 9-month figure less the 6-month figure.Report this figure(17.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$17.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001193125-26-115123. Derived: 12-month figure less the 9-month figure.Report this figure(19.5)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$19.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure(16.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$16.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-346819. Derived: 6-month figure less the 3-month figure.Report this figure(12.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$12.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-280215. Derived: 9-month figure less the 6-month figure.Report this figure(15.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$15.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001193125-26-115123. Derived: 12-month figure less the 9-month figure.Report this figure(20.5)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$20.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure(14.9)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$14.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-346819. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0000950170-24-125929. Derived: 9-month figure less the 6-month figure.Report this figure1.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-27, accession 0000950170-25-046056. Derived: 12-month figure less the 9-month figure.Report this figure0.8Capital expenditure, Q1 FY2024, three months to 2024-03-31$815.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0000950170-25-071427.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$137.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0000950170-25-108054. Derived: 6-month figure less the 3-month figure.Report this figure1.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$989.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-280215. Derived: 9-month figure less the 6-month figure.Report this figure0.8Capital expenditure, Q4 FY2024, three months to 2024-12-31$827.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001193125-26-115123. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$58.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure0.5Capital expenditure, Q2 FY2025, three months to 2025-06-30$493.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-346819. Derived: 6-month figure less the 3-month figure.Report this figure0.9Capital expenditure, Q3 FY2025, three months to 2025-09-30$899.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-280215. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$219.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001193125-26-115123. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$87.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-346819. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)41.84m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares1.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-301,778,255 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-061553.Report this figure21.9Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3121,920,570 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059084.Report this figure22.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3021,971,032 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-095760.Report this figure22.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3022,081,162 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0000950170-24-125929.Report this figure22.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3122,590,804 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0000950170-25-071427.Report this figure36.1Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3036,132,616 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0000950170-25-108054.Report this figure38.1Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3038,105,131 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure38.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3138,350,444 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure38.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3038,461,619 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure38.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3038,560,464 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-280215.Report this figure38.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3138,724,803 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-221634.Report this figure41.8Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3041,841,887 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure

Shares outstanding: 42.85mShares outstanding, period not labelled, at 2026-08-0742,853,362 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-346819.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.